Regents of the University of California’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-4,220
Closed -$247K 103
2013
Q2
$247K Buy
+4,220
New +$247K 0.13% 66